Cancer Hospital CAMS (Beijing)

Beijing · Onkologi · 3A · NCC

Fudan 2022 · #26 3A · NCC

Ikhtisar

Cancer Hospital CAMS (Beijing) adalah rumah sakit unggulan di Beijing, Tiongkok. Rumah sakit ini masuk dalam 100 Besar MedTravelCN karena keunggulannya di bidang Onkologi dan kemampuannya menerima pasien internasional.

Host institution of the National Cancer Center; the flagship national institution for cancer research and standardized treatment.

Informasi utama

Tahun berdiri1958
KotaBeijing
Spesialisasi unggulanOnkologi
Akreditasi3A · NCC
Peringkat Fudan 2022#26

Alamat & lokasi

No. 17 Panjiayuan Nanli, Chaoyang District, Beijing

Departemen unggulan

Medical oncology Thoracic surgery Radiation oncology Pathology

Tren peringkat (peringkat Fudan, rentang referensi)

21-40
2021
11-20
2022
21-40
2023
21-40
2024
21-40
2025

Rentang disusun dari rilis peringkat Fudan 2021-2025, hanya sebagai referensi.

Dokter representatif

  • Prof. He Jie · Thoracic surgery
  • He Jie · Academician, thoracic surgery
  • Xu Binghe · Academician, breast oncology
  • Shi Yuankai · Medical oncology, lymphoma & lung cancer
  • Wang Jie · Thoracic medical oncology
  • Ma Fei · Breast cancer precision therapy
  • Sun Yan · Senior academician, medical oncology

Daftar ahli dari sumber publik dan situs resmi rumah sakit; ketersediaan dan jabatan dapat berubah — verifikasi ke rumah sakit sebelum memesan.

Berita & tonggak sejarah

2011

National Cancer Center established at the hospital (2011)

2023

Breast-cancer expert Xu Binghe elected academician of CAE

2025

National cancer registry reports and early-screening programs continue

2011

National Cancer Center established

The National Cancer Center was established at the hospital, coordinating national cancer control, registry and screening programs.

2023

Xu Binghe elected CAE academician

Breast-cancer expert Xu Binghe was elected academician of the Chinese Academy of Engineering, strengthening the hospital's research leadership.

2024

Leads national cancer quality control

Through the National Cancer Center it drives national quality control, guideline rollout and grassroots support.

2025

Cancer registry annual report continues

Its annual China cancer registry reports provide the evidence base for national and international control policies.

2025

Research wards and innovative-drug trials expand

Research wards provide a regulated platform for drug and device trials, with eligibility assessment for patients.

2025

the Cancer Hospital CAMS holds a top position in the Fudan China Hospital Ranking

In the latest Fudan China Hospital Ranking, the Cancer Hospital CAMS holds the No.1 position in its category, with several specialties in the top specialty lists and a growing national referral volume.

2024

Cancer screening and precision therapy platforms improve

Screening and genomics-guided precision platforms keep improving, with a top national trial portfolio.

2024

National key clinical specialties keep expanding at the Cancer Hospital CAMS

The hospital hosts multiple national key clinical specialties spanning thoracic surgery, breast oncology and medical oncology, steadily strengthening complex care.

2024

Multidisciplinary clinics (MDT) offer one-stop care for complex cases

MDT clinics involving thoracic surgery, breast oncology and other specialties let complex patients receive a joint expert plan in a single visit.

2023

Internet hospital enables remote follow-up

The internet hospital of the Cancer Hospital CAMS supports online revisits, report interpretation and prescription delivery, cutting travel for distant patients.

2023

Cross-province direct medical insurance settlement fully covered

As a designated hospital for cross-province settlement, insured patients can settle bills directly on discharge, easing upfront costs.

2023

Day surgery and ERAS programs mature

Day surgery and enhanced recovery pathways let most routine procedures finish within 24 hours from admission to discharge.

2020

Played a major role in COVID-19 critical care

During the pandemic, the hospital sent successive medical teams to Hubei and other regions while running local critical care.

2022

Paired assistance and medical alliance support grassroots hospitals

Ongoing paired assistance and telemedicine collaboration upgrade grassroots capacity in thoracic surgery and beyond.

2024

A national base for residency training and medical talent

A major national residency training base, the hospital graduates large cohorts of residents, fellows and nurses under internationally aligned curricula.

2025

Clinical research and innovation keep accelerating

The hospital leads or joins numerous national multicenter trials, publishing in authoritative journals and translating findings into practice.

2025

International patient services keep improving

The international desk assists foreign patients with booking, interpretation, cost estimates and insurance, with streamlined workflows.

2022

Smart hospital and digital management recognized

Its smart service and management systems passed national reviews, improving integrated online-offline care.

2023

Nursing excellence and patient safety upgraded

Nursing quality and patient-safety programs were upgraded, with adverse-event monitoring and infection control meeting national standards.

2024

Medical education quality keeps improving

Expanded clinical skills centers apply simulation teaching and OSCE assessments widely.

Tonggak dirangkum dari laporan publik tepercaya dan rilis resmi; judul adalah ringkasan.

Kerja sama internasional

  • Long-term research collaboration with MD Anderson Cancer Center, Institut Curie and other international centers.
  • As the host of the National Cancer Center, it maintains data exchange with IARC and other global bodies.
  • Faculty serve in international oncology societies and host visiting physicians from many countries.
  • Follow-up and health-management communities give overseas patients reminders, report interpretation and medication advice.
  • Faculty of the Cancer Hospital CAMS serve on committees, boards and journal editorial teams internationally, contributing to global guidelines.
  • The hospital hosts international congresses with regular visiting speakers from international cancer research institutions.
  • The hospital accepts international fellows; physicians from international cancer research institutions have completed structured training here.
  • As a teaching hospital, it provides clinical rotations for international medical students from many countries.
  • Cross-border teleconsultation and remote imaging reading are run with overseas medical institutions.
  • The hospital regularly dispatches medical aid teams to developing countries, treating patients and training local doctors.
  • A major choice for overseas Chinese returning for care, with full escort and multilingual services.
  • It takes part in Belt & Road health cooperation, with collaborative ties to hospitals along the routes.
  • Direct-billing agreements with multiple international insurers let foreign patients settle without upfront payment.
  • Joint laboratories and research centers with overseas universities drive collaborative science.
  • Findings keep appearing in authoritative international journals, raising the hospital's global visibility.
  • It keeps introducing advanced international technologies and devices with localized clinical studies.
  • Overseas hospital and health-administration delegations visit regularly in two-way management exchange.
  • Key staff are sent annually for advanced training at international cancer research institutions, lifting departmental capability on return.
  • Its quality and safety systems align with international standards, with some processes internationally certified.
  • Participation in international multicenter trials adds Chinese data for global patients.

Informasi kerja sama dirangkum dari sumber publik; merujuk rilis resmi rumah sakit.

Kolaborasi universitas

Peking Union Medical College

Riset & publikasi

Runs national cancer registration and guideline programs and leads international multi-center oncology trials.

Dirangkum dari sumber publik (Oktober 2026). Cek situs resmi rumah sakit sebelum berangkat.

Baca proses perjalanan medis ← Kembali ke peringkat rumah sakit